This opportunity is no longer accepting applications.
grant PAR-24-072

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

The National Cancer Institute (NCI) is offering funding for investigator-initiated clinical trials aimed at reducing cancer burden. These trials should focus on improving areas such as early detection, screening, prevention, healthcare delivery, quality of life, or survivorship, and should have the potential to enhance clinical practice or public health. Eligible studies must align with the NI…

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: December 15, 2023
Open for Submission: December 15, 2023
Submission Deadline: January 7, 2027
Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.